Perioperative brain natriuretic peptide in off-pump coronary artery bypass

Acta Cardiologica

Volumn 65, Issue 3, 2010, Pages 297-301

  Wang, Zanxin ^a   Liang, Degang ^a   Fu, Qiang ^a   Jia, Liqun ^a   Men, Jianlong ^b   Wei, Minxin ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Dept of Clinical Laboratory ^*  (China)

Author keywords

Brain natriuretic peptide; Myocardial injury; Off pump coronary artery bypass graft surgery

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB; ESMOLOL; HEPARIN; MIDAZOLAM; MORPHINE; SUFENTANIL; VECURONIUM;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; PERIOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; RISK FACTOR;

AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS, OFF-PUMP; CREATINE KINASE, MB FORM; ECHOCARDIOGRAPHY; FEMALE; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RESPIRATION, ARTIFICIAL; RISK FACTORS; STATISTICS, NONPARAMETRIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77955789185     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.65.3.2050345     Document Type: Article

References (26)

1. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008; 358: 2148-59.
2. Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU, Lloyd-Jones DM, Brown DF, Foran-Melanson S, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005; 95: 948-54. (Pubitemid 40487743)
3. Woodard GE, Rosado JA. Natriuretic peptides in vascular physiology and pathology. Int Rev Cell Mol Biol 2008; 268: 59-93.
4. Logeart D, Lecuyer L, Thabut G, Tabet JY, Tartière JM, Chavelas C, Bonnin F, Stievenart JL, Solal AC. Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism. Intensive Care Med 2007; 33: 286-92.
5. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M; ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 1943-50.
6. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355: 1126-30.
7. Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, Aupetit JF, Aumont MC, Galinier M, Eicher JC, Cohen-Solal A, Juillière Y. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 2007; 49; 1733-9. (Pubitemid 46589928)
8. Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton C, Turner J, Crozier IG, Yandle TG. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003; 107: 2786-92.
9. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, Hall C, Cannon CP, Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1057-9.
10. Scarborough JE, White W, Derilus FE, Mathew JP, Newman MF, Landolfo KP. Neurologic outcomes after coronary artery bypass grafting with and without cardiopulmonary bypass. Semin Thorac Cardiovasc Surg 2003; 15: 52-62. (Pubitemid 36758251)
11. Wei M, Kuukasjarvi P, Laurikka J, Kaukinen S, Iisalo P, Laine S, Laippala P, Metsänoja R, Tarkka M. Cytokine responses and myocardial injury in coronary artery bypass grafting. Scand J Clin Lab Invest 2001; 61: 161-6.
12. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP; TIME-CHF Investigators. BNP-guided vs. symptom-guided heart failure therapy: the Trial of Intensified vs. Standard Medical Therapy in Elderly Patients with Congestive Heart Failure (TIME-CHF) randomized trial. JAMA 2009; 301: 432-4.
13. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004; 43: 635-41. (Pubitemid 38229537)
14. Parekh N, Maisel AS. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure. Curr Opin Cardiol 2009; 24: 155-60.
15. Vinereanu D, Florescu N, Sculthorpe N, Tweddel AC, Stephens MR, Fraser AG. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol 2001; 88: 53-8.
16. Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, Goto Y, Nonogi H. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006; 47: 742-8.
17. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, Pinto YM, Richards M. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006; 27: 330-7. (Pubitemid 43100029)
18. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, Duc P, Westheim A, Omland T, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Circulation 2002; 106: 416-22.
19. De Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362: 316-22.
20. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA; Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-7.
21. Sinha AM, Breithardt OA, Schmid M, Stellbrink C. Brain natriuretic peptide release in cardiac surgery patients. Thorac Cardiovasc Surg 2005; 53: 138-43. (Pubitemid 40827249)
22. Berendes E, Schmidt C, Van Aken H, Hartlage MG, Rothenburger M, Wirtz S, Scheld HH, Brodner G, Walter M. A-type and B-type natriuretic peptides in cardiac surgical procedures. Anesth Analg 2004; 98: 11-9. (Pubitemid 38029833)
23. Akazawa T, Nishihara H, Iwata H, Warabi K, Ohshima M, Inada E. Preoperative plasma brain natriuretic peptide level is an independent predictor of postoperative atrial fibrillation following off-pump coronary artery bypass surgery. J Anesth 2008; 22: 347-53.
24. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, Duc P, Westheim A, Omland T, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002; 106: 416-22. (Pubitemid 34803684)
25. Dernellis J, Panaretou M. Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients. Heart 2006; 92: 1645-50.
26. Moazami N, Damiano RJ, Bailey MS, Hess RL, Lawton JS, Moon MR, Pasque MK. Nesiritide (BNP) in the management of postoperative cardiac patients. Ann Thorac Surg 2003; 75: 1974-6. (Pubitemid 36677259)